Product
Loteprednol Etabonate
2 clinical trials
3 indications
Indication
Corneal Endothelial DystrophyIndication
Corneal EdemaIndication
Dry EyeClinical trial
Prospective Analysis of Loteprednol Etabonate Ophthalmic Suspension 0.25% for Prevention of Immunologic Rejection After Descemet Membrane Endothelial KeratoplastyStatus: Completed, Estimated PCD: 2023-09-05
Clinical trial
Intracanalicular Dexamethasone Used in Conjunction With Restasis (Cyclosporine Ophthalmic Emulsion) for the Treatment of Signs and Symptoms of Dry Eye Disease as Compared to Restasis With Lotemax (Loteprednol Etabonate Ophthalmic Suspension 0.5%) and Restasis Monotherapy.Status: Completed, Estimated PCD: 2022-02-16